LON: System, Test, Automated, Antimicrobial Susceptibility, Short Incubation
What it covers
A fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.
The identification in 21 CFR 866.1645, fully automated short-term incubation cycle antimicrobial susceptibility system. FDA gives LON no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260283 | VITEK 2 AST-Streptococcus Meropenem (=0.06 - =4 µg/mL) | bioMerieux, Inc. | Oct 1, 2026 | Traditional |
| K260619 | VITEK 2 AST-Streptococcus Cefepime (<=0.06 >=4 µg/mL) | Biomérieux, Inc. | Sep 28, 2026 | Traditional |
| K260282 | VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance | bioMerieux, Inc. | Apr 15, 2026 | Traditional |
| K260281 | VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) | BIOMERIEUX | Mar 26, 2026 | Traditional |
| K251579 | VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL) | bioMerieux, Inc. | Aug 21, 2025 | Traditional |
| K251713 | BD Phoenix Automated Microbiology System - GN Eravacycline (0.125-2 µg/mL) | Becton, Dickinson and Company | Aug 8, 2025 | Traditional |
| K250447 | BD Phoenix Automated Microbiology System - GN Imipenem-relebactam (0.0625/4 - 16/4 µg/mL) | Becton, Dickinson and Company | May 19, 2025 | Traditional |
| K234012 | VITEK COMPACT PRO | bioMerieux, Inc. | Mar 14, 2025 | Traditional |
| K250344 | BD Phoenix Automated Microbiology System | Becton, Dickinson and Company | Mar 6, 2025 | Special |
| K233986 | BD Phoenix Automated Microbiology System - GN Ciprofloxacin (0.01564 µg/mL) | Becton, Dickinson and Company | Mar 15, 2024 | Traditional |
Clearances by year
94 LON 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 4 | 146 |
| 2025 | 5 | 90 |
| 2024 | 2 | 86 |
| 2023 | 11 | 210 |
| 2022 | 8 | 189 |
| 2021 | 5 | 268 |
| 2020 | 5 | 81 |
| 2019 | 8 | 84 |
| 2018 | 4 | 88 |
| 2017 | 10 | 89 |
| 2016 | 3 | 242 |
| 2014 | 4 | 90 |
| 2013 | 7 | 115 |
| 2012 | 10 | 200 |
| 2011 | 8 | 85 |
Who submits
10 applicants cleared a LON device since 2011. 98% of the clearances went to applicants in United States, then Italy (2%). By type: Traditional 98% and Special 2%.
| Applicant | Clearances since 2011 |
|---|---|
| bioMerieux, Inc. | 68 |
| Becton, Dickinson and Company | 14 |
| Becton, Dickinson & CO | 2 |
| Biomérieux, Inc. | 2 |
| Copan Wasp Srl | 2 |
| Selux Diagnostics, Inc. | 2 |
| Beckman Coulter, Inc. | 1 |
| Becton Dickinson & Company | 1 |
How FDA classifies it
Class II (special controls). The special control for this device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA.”
From 21 CFR 866.1645. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 866.1645 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LON clearances declared.
Ask about LON
Questions about LON
What is FDA product code LON?
Product code LON, “System, Test, Automated, Antimicrobial Susceptibility, Short Incubation” in FDA's classification database, is a Class II device type under 21 CFR 866.1645 (fully automated short-term incubation cycle antimicrobial susceptibility system), reviewed by FDA's Microbiology panel. FDA's 510(k) database lists 291 clearances under LON, 94 of them since 2011.
How many 510(k) clearances are there under LON?
FDA’s 510(k) database listed 291 clearances under LON as of Oct 29, 2026, 94 of them decided since 2011; the most recent decision was Oct 1, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a LON 510(k)?
For the 9 LON clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 90 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LON clearances?
Since 2011: bioMerieux, Inc. (68), Becton, Dickinson and Company (14), Becton, Dickinson & CO (2), Biomérieux, Inc. (2) and Copan Wasp Srl (2). 10 applicants have cleared a LON device in that time.